Stéphane Prost Selected Research

Vaccinia

9/2004

Efficient priming of simian/human immunodeficiency virus (SHIV)-specific T-cell responses with DNA encoding hybrid SHIV/hepatitis B surface antigen particles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stéphane Prost Research Topics

Disease

3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2017 - 02/2014
2	Neoplasms (Cancer) 12/2017 - 09/2015
1	Weight Gain 01/2017
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 09/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2008
1	Vaccinia 09/2004

Drug/Important Bio-Agent (IBA)

2	Tyrosine Kinase InhibitorsIBA 12/2017 - 02/2014
2	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 02/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	Pioglitazone (Actos)FDA Link 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2015
1	Oncogene Proteins (Oncogene Protein)IBA 09/2015
1	PPAR gammaIBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 09/2004
1	HIV AntigensIBA 09/2004

Therapy/Procedure

2	Therapeutics 09/2015 - 02/2014